Insider Selling: Waystar (NASDAQ:WAY) CEO Sells $562,448.48 in Stock

Waystar Holding Corp. (NASDAQ:WAY) CEO Matthew Hawkins sold 22,462 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $25.04, for a total value of $562,448.48. Following the completion of the sale, the chief executive officer directly owned 1,835,081 shares of the company’s stock, valued at $45,950,428.24. The trade was a 1.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Waystar Stock Down 1.2%

NASDAQ:WAY opened at $24.78 on Friday. The company has a market cap of $4.75 billion, a price-to-earnings ratio of 35.40, a price-to-earnings-growth ratio of 0.96 and a beta of 0.06. Waystar Holding Corp. has a twelve month low of $17.26 and a twelve month high of $41.47. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. The stock has a fifty day simple moving average of $21.62 and a 200-day simple moving average of $22.78.

Waystar (NASDAQ:WAY) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. The company had revenue of $319.67 million during the quarter, compared to analyst estimates of $316.21 million. Waystar had a net margin of 11.18% and a return on equity of 7.03%. The firm’s revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 earnings per share. Analysts anticipate that Waystar Holding Corp. will post 1.47 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Needham & Company LLC restated a “buy” rating and set a $33.00 target price on shares of Waystar in a research report on Thursday, July 30th. Citigroup restated a “buy” rating on shares of Waystar in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $39.00 price target on shares of Waystar in a research report on Friday, July 31st. Barclays raised their price objective on shares of Waystar from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, August 7th. Finally, Wolfe Research raised shares of Waystar to an “outperform” rating in a report on Thursday. Three equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $35.00.

Institutional Trading of Waystar

Large investors have recently added to or reduced their stakes in the stock. Clarkston Capital Partners LLC acquired a new stake in Waystar during the first quarter worth $22,917,000. Hsbc Holdings PLC acquired a new position in shares of Waystar in the 1st quarter valued at $5,625,000. Renaissance Capital LLC acquired a new position in shares of Waystar in the 4th quarter valued at $2,273,000. Dimensional Fund Advisors LP grew its holdings in shares of Waystar by 73.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,046,396 shares of the company’s stock worth $49,329,000 after purchasing an additional 868,853 shares during the period. Finally, Advisors Preferred LLC purchased a new stake in Waystar in the 4th quarter valued at about $3,975,000.

Waystar Company Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.